DaVita (NYSE:DVA) Stock Price Down 4.2% – Time to Sell?

DaVita Inc. (NYSE:DVA)’s share price was down 4.2% on Monday . The company traded as low as $147.81 and last traded at $148.99. Approximately 169,539 shares were traded during trading, a decline of 79% from the average daily volume of 821,029 shares. The stock had previously closed at $155.51.

Analyst Ratings Changes

A number of research analysts recently issued reports on DVA shares. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. StockNews.com raised shares of DaVita from a “hold” rating to a “buy” rating in a report on Thursday. Cowen reissued a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays raised their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, DaVita currently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Stock Down 3.4 %

The stock’s fifty day simple moving average is $152.13 and its two-hundred day simple moving average is $156.59. The company has a market capitalization of $12.02 billion, a price-to-earnings ratio of 13.99, a P/E/G ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

Hedge Funds Weigh In On DaVita

Hedge funds and other institutional investors have recently modified their holdings of the stock. UMB Bank n.a. boosted its holdings in shares of DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $29,000 after buying an additional 76 shares during the period. Copia Wealth Management purchased a new position in DaVita during the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. acquired a new stake in DaVita during the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC lifted its holdings in shares of DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after purchasing an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita during the fourth quarter valued at $55,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.